Mumps, Measles and Rubella Vaccine
Rationale If you are pregnant and then afflicted with rubella, your child may acquire some deformities and abnormalities. Mumps may lead to orchitis and infertility in the future. Measles could lead to blindness, especially among children. Thus, you need to avail of this vaccination with dispatch. Generic and brand names The generic name is Measles, Mumps, and Rubella Vaccine Live. The brand name is M-M-R II. Composition of the vaccine When reconstituted as directed, the dose for injection is 0.5 ml and contains not less than 1,000 CCID50 (50% cell culture infectious dose) of measles virus; 12,500 CCID50 of mumps virus; and 1,000 CCID50 of rubella virus. Mechanism of action Upon injection, your body responds by producing antibodies against mumps, measles, and rubella. Schedule of administration The dose is given at any time over the age of 12 months. Indications and usage M-M-R is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older. This vaccination is also recommended for measles and mumps outbreaks. In addition, this is recommended for non-pregnant adolescent and adult females of childbearing age to serve as protection against subsequently acquiring rubella infection during pregnancy, which, in turn, prevents infection of the fetus and consequent congenital rubella injury.